Kühn, Simone
Mascherek, Anna http://orcid.org/0000-0001-7923-080X
Banaschewski, Tobias http://orcid.org/0000-0003-4595-1144
Bokde, Arun L. W.
Büchel, Christian
Quinlan, Erin Burke
Desrivières, Sylvane http://orcid.org/0000-0002-9120-7060
Flor, Herta
Grigis, Antoine
Garavan, Hugh
Gowland, Penny
Heinz, Andreas
Ittermann, Bernd
Martinot, Jean-Luc
Martinot, Marie-Laure Paillère
Nees, Frauke
Orfanos, Dimitri Papadopoulos
Paus, Tomáš
Poustka, Luise
Millenet, Sabina
Fröhner, Juliane H.
Smolka, Michael N. http://orcid.org/0000-0001-5398-5569
Walter, Henrik http://orcid.org/0000-0002-9403-6121
Whelan, Robert
Schumann, Gunter
Lindenberger, Ulman http://orcid.org/0000-0001-8428-6453
Gallinat, Jürgen
Article History
Received: 5 September 2019
Accepted: 9 January 2020
First Online: 27 January 2020
Competing interests
: Dr. Banaschewski has served as an advisor or consultant to Bristol-Myers Squibb, Desitin Arzneimittel, Eli Lilly, Medice, Novartis, Pfizer, Shire, UCB, and Vifor Pharma; he has received conference attendance support, conference support, or speaking fees from Eli Lilly, Janssen McNeil, Medice, Novartis, Shire, and UCB; and he is involved in clinical trials conducted by Eli Lilly, Novartis, and Shire; the present work is unrelated to these relationships. The other authors report no biomedical financial interests or potential conflicts of interest.